Nomura recommends purchasing shares of Eureka Forbes, predicting a price of INR 600 per share, due to Q4's strong earnings and expectations of higher profit margins from new products and price increases.

Eureka Forbes aspires to double its revenue and triple its earnings before interest, taxes, depreciation, and amortization (EBITDA) by the financial year 2030. To accomplish this goal, they are focusing on an expansion of their health technology sector.

Eureka Forbes records a 12% increase in Q4 revenues, attributed to robust sales of water purifiers and robotics products.

Eureka Forbes reports a revenue of INR 2710.5 crore and Profit Before Tax (PBT) of INR 215.7 crore for the financial year 2026, as per their approved results with an unmodified audit opinion.

Eureka Forbes reported a 3% increase in Q4 net profit, reaching Rs 51 crore, and saw a significant 12% jump in revenue at Rs 684 crore compared to last year. The company's EBITDA also experienced growth, rising by 11.3% to Rs 85.8 crore.

Eureka Forbes has set ambitious goals, aiming to double its revenue and tripling its EBITDA within the next five years, signaling a strong commitment to growth and profitability.

Eureka Forbes experienced a 10% increase in Q4 EBITDA, reaching INR 856 million, but the EBITDA margin dipped slightly compared to last year.